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Human genetic and in vivo animal studies have helped to
define the critical importance of podocytes for kidney
function in health and disease. However, as in any other
research area, by default these approaches do not allow for
mechanistic studies. Such mechanistic studies require the
availability of cells grown ex vivo (i.e., in culture) with the
ability to directly study mechanistic events and control
the environment such that specific hypotheses can be tested.
A seminal breakthrough came about a decade ago with the
documentation of differentiation in culture of primary rat and
human podocytes and the subsequent development of
conditionally immortalized differentiated podocyte cell lines
that allow deciphering the decisive steps of differentiation
and function of ‘in vivo’ podocytes. Although this paper is not
intended to provide a comprehensive review of podocyte
biology, nor their role in proteinuric renal diseases or
progressive glomerulosclerosis, it will focus specifically on
several aspects of podocytes in culture. In particular, we will
discuss the scientific and research rationale and need for
cultured podocytes, how podocyte cell-culture evolved, and
how cultured podocytes are currently being used to uncover
novel functions of podocytes that can then be validated
in vivo in animal or human studies. In addition, we provide a
detailed description of how to properly culture and
characterize podocytes to avoid potential pitfalls.
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RATIONALE FOR THE NEED OF PODOCYTES IN CULTURE
The study of kidney disease is complex because the onset is
often undetected, diseases may be acute or chronic in nature,
the genetic makeup of the host leads to variable clinical
syndromes, and multiple organs are often involved simulta-
neously. To study disease susceptibility, mechanisms, prog-
nosis, and potential therapies, most authorities, including the
authors, would say that studying humans is ideal and, in
most instances, this is the gold standard. However, this is not
always possible and we would argue that this is an exception
rather than a rule. Moreover, many diseases, in particular
kidney diseases, are not that common in the general
population, thus increasing the challenge of limiting studies
to man. There is no doubt that the research questions should
primarily stem from patients with kidney disease. However,
studies verifying proof of principle are limited, if not
impossible in man.
Thus, in renal and nonrenal research, the use of
experimental models in animals has proved invaluable.
Moreover, the genome era with the development of null or
transgenic mice, and more recently, with the ability to restrict
or delete expression to a specific cell, has significantly
advanced our understanding of many aspects of kidney
disease. Nevertheless, animal models are often limited
because they do not always fully replicate their human
counterpart. For example, the current mouse models of
diabetic nephropathy do not typically demonstrate the
features of the human disease such as Kimmelstiel–Wilson
nodules. Moreover, there are no mouse models of other
podocyte diseases such as membranous nephropathy and the
background mouse strain plays a critical role in disease
initiation and progression.1 Similarly, while positional
cloning has proven invaluable and has uncovered mutations
such as those in phospholipase C epsilon (PLCE1) underlying
nephrotic syndrome, PLCE1-null mice do not have any
overt phenotype,2 suggesting that animal models too may
be limited. Yet, well-characterized animal models do
provide insights into disease, albeit often descriptive, and
in many instances, provide a good starting point for the
decision to try a particular therapy in human disease. Most
significantly, however, despite the many merits of transgenic/
null mice and animal models, they do not, by default,
allow for mechanistic studies, calling for the use of cells
grown in vitro.
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WHERE DID CELL-CULTURE STUDIES BEGIN?
The initial studies using cells from either man or animals
grown in culture date back to the 1950,3–5 including cells
derived from the kidney.6 Although cells grown ex vivo (i.e.,
in culture) do not fully replicate the in vivo environment,
they have several major advantages. These include the ability
to directly study mechanistic events, to control the environ-
ment such that specific hypotheses can be tested, and that
multiple experiments can be performed to validate the initial
observations. Although perhaps obvious, it is critical to use
podocytes in culture to study events related to podocytes.
Thus, although informative, the use of other cells such as
human embryonic kidney cell line, COS, and mouse
embryonic fibroblasts (MEFs) to study podocytes is not fully
representative and thus has the potential to be erroneous.
Although these nonpodocyte cells might be useful to initially
characterize novel protein:protein interactions, they are not
podocytes and therefore the functional relevance of these
novel interactions need to be confirmed in podocytes to
generalize these findings to podocytes.
There is a large body of literature using cells in culture in
cardiac, central and peripheral nervous system, liver, blood,
immune, and other organ-system research. Each cell-culture
system has unique properties and characteristics that differ
from others and podocytes are no exception. In this review
we will provide comprehensive and compelling support that
the study of podocytes in culture is a valid and invaluable
model system, when used together with animal models and
human studies, to uncover novel and mechanistic events in
these important cells. It is our belief that with each model
system (man, animal, cells), validation of the results need to
be confirmed with a different model system.
THE PAST: HISTORY OF PODOCYTES IN CULTURE
Cultivation of podocytes in vitro was first introduced in the
mid-1970s7–9 and glomerular epithelial cells in culture from a
variety of species have since been described in man,7,8,10–12
pigs,13 rats,14–16 and mice.17,18 The first step in culturing
podocytes is based on the isolation of encapsulated or
decapsulated glomeruli from kidney cortex.9 A good
preparation is considered when 95% of the cellular
constituents are glomeruli, with the remainder comprising
tubules. Thus, to further reduce tubular contaminations (and
enhance the percentage of glomeruli in the preparation), a
Ficoll-gradient centrifugation step may be included.19 After 4
or 5 days of primary culture, a monolayer of cobblestone-like
epithelial cells is observed. However, since the beginning of
these pioneering experiments substantial doubts about the
origin and validity of the cells growing out from the isolated
glomeruli have been raised.20–22 Subsequent studies showed
that this uncertainty could be ruled out by starting the
generation of primary cultures specifically in manually
selected decapsulated glomeruli that are devoid of parietal
epithelium.11,16 The presence of podocytes in culture was
further supported by the observation that differentiated
podocytes can leave their position on the glomerular
basement membrane and migrate onto the surface of
cultured kidney slices.23
After the isolation of glomeruli, two alternative protocols
have been used that ultimately lead to similar results, the
generation of primary cultures of podocytes. In the first
protocol, isolated glomeruli are generally cultured for 4 or 5
days before they are subcultured by passing trypsinized
glomerular outgrowths over sieves with 25 mm pore size to
remove the remaining glomerular cores consisting mainly of
mesangial and endothelial cells.24 In the second protocol,
isolated glomeruli are digested with collagenase for 30 min,
passed over a sieve with 25 mm pore size and the cells that
pass through the sieve are used for cultivation.25 In both
protocols, cells are routinely plated on type I collagen-coated
dishes to promote cell proliferation. The proliferating cells
form a monolayer of cobblestone appearance. As they reach
confluence, the cells are subcultured after trypsinization
or collagenase treatment. The media used varied from
Dulbecco’s modified Eagle’s medium or RPMI 1640 supple-
mented with 5–20% fetal calf serum13 or 3T3-fibroblast-
conditioned medium24 to hormonally defined serum-free
media.26 The cells obtained under these conditions have
mostly been used as primary cultures or as early subcultures
of primary outgrowths,14,27,28 but in addition permanent and
nonpermanent cell lines have been established.10,11,15,17,18
Despite advancing the field, these cells were still not ideal and
the quest for the cell that replicates the in vivo counterpart
was only just beginning.
CLUES TO UNLOCKING THE TRUE IN VITRO PODOCYTE
PHENOTYPE: THE TALE OF TWO DIFFERENT PHENOTYPES
OF CULTURED PODOCYTES
As discussed above, early on the cobblestone-type cells were
the first to be used to investigate podocyte function in
culture because these cells were able to survive under cell culture
conditions. However, in these early studies the unspecific
cobblestone-appearance of the cells was used as the sole
characteristic to prove that the glomerular outgrowths were
podocyte-derived.9 A breakthrough emerged in that the
identification of podocytes was advanced by the demonstra-
tion of podocyte ‘markers’ including TN1029 and podo-
calyxin.10,11 Of note, podocalyxin is not specific for
podocytes because it is also expressed by endothelial cells.30
Thus, podocycalyxin alone is not sufficient to prove that cells
in culture are podocytes. Expression of intermediate filament
proteins (e.g., cytokeratin, vimentin, or desmin) and cell
junction proteins (e.g., ZO-1) have also been used, but they
too do not allow definitive proof of origin of cultured
podocytes, since they are also expressed in other cell types.
Thus, their presence or absence in cultured podocytes should
rather be seen in the light of mimicking in vitro the
developmental modulations of these proteins observed
during podocyte maturation in vivo.31–35
Another major problem associated with culturing podo-
cytes had been the historical rapid dedifferentiation in vitro
that accompanies the loss of the specific cell architecture and
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results in the cobblestone morphology of ‘standard’ podo-
cytes in culture. The latter share many features with
immature podocyte precursor cells during early glomerular
development, including the lack of synaptopodin expression
(see below). Their low degree of differentiation is also
reflected by the reappearance of lymphohaemopoietic marker
antigens36 expressed in vivo only transiently during the early
stages of podocyte development.37
A second type of epithelial cells growing out from isolated
glomeruli shows a different phenotype (Figure 1b). These are
large (up to 500 mm) arborized, often binucleated cells that
exhibited no proliferative activity. This obviously limited
propagation and the ability to establish a cell line in vitro. A
novel discovery was that in contrast to cobblestone cells,
these cells expressed synaptopodin.16,38 Synaptopodin is a key
marker of a differentiated podocyte phenotype, because
in vivo the expression of synaptopodin is specific to
postmitotic differentiated podocytes.39 Arborized podocytes
had been reported to contribute between 10% of rat16 and
almost 100% of cultured porcine glomerular epithelial cell,13
both after roughly 10 days of culture.
THE PRESENT: INDUCTION OF DIFFERENTIATION IN
CULTURED RAT AND HUMAN PODOCYTES
In the mid-1990s, serious efforts were undertaken to develop
a podocyte culture model that would demonstrate in vitro
expression of synaptopodin, a key marker of differentiated
podocytes in vivo.39 This effort was motivated by the
observation discussed above that the cultivation of podocytes
under then standard conditions leads to rapid dedifferentia-
tion, including the loss of processes and synaptopodin
expression.39 It was further motivated by the fact that
synaptopodin is not expressed in other cells such as
fibroblasts, suggesting that results obtained from studying
synaptopodin in fibroblasts or other model cell lines would
not necessary reflect its true function in podocytes. To
optimize the in vitro characteristics, we modified the culture
conditions for rat and human podocytes by simply avoiding
repeated subcultivation.38 This led to profound phenotypic
changes in podocytes in vitro, including the conversion
of cells with the cobblestone phenotype into cells with
the characteristic arborized phenotype that more closely
resemble in vivo podocytes. Both cobblestone and
arborized cells originate from podocytes, as evidenced by
the expression of a podocyte-specific O-acetylated ganglio-
side40 and WT-1.41 The differentiation into arborized cells
leads to growth arrest and is reflected by the formation of
processes and the expression of synaptopodin, which was
never detected in cobblestones. Taken together, we achieved
(partial) differentiation of cultured podocytes by avoiding
repeated subcultivation, resulting in a phenotype more
closely reflecting in vivo podocytes.38 Although these
results were indeed satisfying, there was still room for
improvement.
A MAJOR BREAKTHROUGH: CONDITIONALLY IMMORTALIZED
MURINE PODOCYTES RETAIN A DIFFERENTIATION
POTENTIAL SIMILAR TO THEIR IN VIVO COUNTERPARTS
The differentiation of primary human and rat podocytes
results in rapid growth arrest.38 Although this reflects the
mature in vivo counterpart, it limits cell culture abilities
because passaging cells that do not increase in number is
technically problematic. To circumvent this problem, we took
advantage of the Immortomouse42 and established condi-
tionally immortalized mouse podocyte cell lines, which are
highly proliferative when cultured under permissive condi-
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Figure 1 | Light microscopic morphology of cultured podocyte. (a) Podcytes grown under permissive conditions (at 331C with 20 U/ml INF-g)
display a characteristic cobblestone morphology. The cells form an epithelial monolayer as they reach confluence. (b) Differentiating (3, 7) and
differentiated (14) podocytes grown under nonpermissive conditions (days at 371C, no INF-g). Under nonpermissive conditions, the cells
develop interdigitating processes, which are only connected at sites of process interdigitations. On day 14, large, flat arborized cells with
well-developed prominent processes can be seen.
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tions. The details are described elsewhere.43 In brief,
nonpermissive conditions render the majority of podocytes
growth arrested within 6 days and induce many characte-
ristics of differentiated podocytes (Table 1). Both proliferat-
ing and differentiating podocytes express WT-1. During
differentiation, an ordered array of actin fibers and micro-
tubules started to extend into the forming cellular processes,
reminiscent of podocyte processes in vivo.43 Similar to
primary cultures,38 the cytoskeletal rearrangement and
process formation were accompanied by the onset of
synaptopodin expression. Moreover, electrophysiological
studies showed that differentiated murine podocytes
respond to bradykinin by changes in intracellular calcium
concentration.
Taken together, these studies established for the first time
that conditionally immortalized murine podocytes in vitro
retain a differentiation potential similar to podocytes in
vivo,43 including the formation of slit-diaphragm-like cell–cell
contacts44,45 (Figure 2). This breakthrough has since made it
possible to explore the molecular mechanisms underlying
podocyte differentiation and function using an inducible in
vitro model.43 Of note, despite published46,47 and unpub-
lished claims (Table 1), when properly cultured (see below),
these cells express virtually all proteins described in
podocytes to date, including among others: a3b1 integrin,48
a-actinin-4,49–51 angiotensin 2 receptor52, B7-1,53
CD2AP,54,55 ILK,56 myosin II,51 Nck1/2,57 nephrin,50,53
P-cadherin,44 Pod1,58 podocalyxin,58 podocin,50,53 synapto-
podin,43 TRPC6,59 transforming growth factor-b,60 vascular
endothelial growth factor,61,62 and WT-158 (Table 2).
HOW CULTURED PODOCYTES HAVE ADVANCED THE FIELD
IN HEALTH AND DISEASE BEYOND IN VIVO STUDIES
Podocytes in culture are now being widely used to study
virtually all aspects of podocyte biology in health and disease
(Table 3). These innovative studies by laboratories through-
out the world include the regulation of the cytoskele-
ton,49,51,63–68 cell cycle,69–71 survival,72,73 signaling56,58,74–79
cell:cell,53,80 and cell:matrix adhesion48,81 as well as podocyte
channel physiology.68,82–85 Table 3 also shows how podocytes
in culture have been successfully used to gain mechanistic
insight into the role of podocytes in the pathogenesis of
diabetic62,86 and human immunodeficiency virus-associated
nephropathy.87–89 Here, we will highlight two recent exam-
ples because they exemplify how podocytes in culture have
helped to explore the function of proteins in podocytes,
which could have not come from in vivo studies, because the
protein is not expressed in healthy podocytes (B7-153) or
because the protein is dispensable for healthy podocytes but
has an important protective role under pathologic (stressed)
conditions (cyclin I71).
What we have learned from the B7-1 experience and
cultured podocytes: for a variety of reasons beyond the
scope of this review, we developed cultured podocytes
from a3 integrin-deficient (a3/) mice that bear a strong
morphological resemblance to podocytes in congenital
nephrotic syndrome and other pathological conditions
with foot process (FP) effacement.90,91 These a3/ podo-
cytes allowed us to uncover an unanticipated novel role
for costimulatory molecule B7-1 in podocytes as an
inducible modifier of glomerular permselectivity.53 In
particular, this study was the first to demonstrate that B7-1
is expressed in podocytes under a variety of stressed
conditions, in culture, and in vivo, both in experimental
and human proteinuric kidney diseases. We specifically
showed that podocyte B7-1 reorganizes the actin cytoskeleton
of podocytes and modulates slit diaphragm (SD) organiza-
tion. Most significantly, the effects of B7-1 in podocytes were
found independent of T and B cells and represent a novel
unique function of B7-1.53 As discussed above, these result
most probably would have not come from in vivo studies,
because B7-1 is not expressed in healthy podocytes.53
Similarly, cyclin I is constitutively expressed in normal
podocytes but its function remained unclear. Cyclin I/
mice develop normally and have no renal phenotype.
Surprisingly, cyclin I/ podocytes in culture revealed a
novel role for this enigmatic cyclin by enhancing podocyte
survival following injury. Once a role for cyclin I in podocyte
survival was uncovered in culture, its role was confirmed in a
disease model in vivo.71
Table 1 | Similarities between podocytes in vitro and in vivo: if they look, smell, and act like a podocyte, they are probably
podocytes
Anti-cell culture view Pro-cell culture view Refs.
Cultured podocytes lack slit
diaphragms
They express a slit diaphragm-like structure Reiser et al.44 and Gao et al.45
Cultured podocytes lack expression
of podocyte-specific proteins
They stably express the vast majority, if not all, of the podocyte-specific
proteins described in vivo
See Table 2
They represent a nonquiescent
phenotype
PCNA, Brdu, cyclins E, A, and M are absent in differentiated podocytes
grown at 371C, consistent with a quiescent phenotype
Mundel et al.,43 Griffin et al.,70,71
and Hiromura et al.95
FACS analysis further supports cell-cycle exit
Cultured podocytes are not
exposed to hemodynamic effects
Mechanical stretch is available if deemed necessary Endlich et al.51
Full differentiation in metanephric kidney culture is possible in the
absence of hemodynamic effects
Nagata et al.96
FACS, fluorescence-activated cell sorting; PCNA, proliferating cell nuclear antigen.
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HOW TO PROPERLY CULTURE PODOCYTES: SHORTCUTS
WILL LEAVE YOU FLATFOOTED
As discussed earlier, podocytes in vivo typically do not
proliferate.92 Thus, to replicate this nonproliferative termi-
nally differentiated and highly specialized phenotype in vitro,
special cell-culture conditions are required. To generate large
numbers of cells, cells are first grown under growth-
permissive conditions, where immortalized podocytes repli-
cate. Growth media consists of RPMI 1640 (or Dulbecco’s
modified Eagle’s medium) containing 10% fetal bovine
serum supplemented with 20–100 U/ml of mouse interferon
gamma (INF-g) to drive T-antigen expression.43 The culture
dishes are usually coated with type I collagen to promote
podocyte proliferation. As the tsA58 mutant T antigen is
temperature sensitive,42 a culture temperature of 331C is
required, which must be carefully monitored in the incubator
(see below). To silence the tsA58 T antigen, thereby inducing
cell cycle exit and differentiation, the cultures are then
switched to medium lacking INF-g and transferred to an
incubator set at 371C. The removal of INF-g from the culture
media results in the loss of IFN-g-driven H-2Kb-promotor
activity42 and the higher temperature of 371C causes the
degradation of the remaining tsA58 T antigen.43 Again, the
a
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Figure 2 | Morphologic comparison of the slit diaphragm complex
in vivo and in vitro. (a) Tangential section of the slit diaphragm
in situ reveals a zipper-like structure with a central linear bar
(asterisk). At the cytoplasmic insertion site, electron-dense material is
observed (arrow). (b) A similar junction is observed between
processes of cultured podocytes. As in vivo, the intercellular space
(asterisk) is 25– 40 nm wide and electron-dense material is found at
the cytoplasmic insertion site (arrow). (c) Low-power micrograph
showing the longitudinal orientation of the junction between foot
process-like processes of two adjacent podocytes (arrows). Original
magnification in (a)  65 000, (b)  70 000, and (c)  9500. Reprinted
from Reiser et al. (2000)44 (with permission).
Table 2 | Taking advantage of the expression of podocyte
proteins by podocytes in vivo to use as markers of cell
specificity in vitro
Podocyte protein Refs.
a3b1 integrin Reiser et al.48
a-Actinin-4 Asanuma et al.,49 Fan et al.,50
and Endlich et al.51
Angiotensin 2 receptor Durvasula et al.52
B7-1 Reiser et al.53
CD2AP Shih et al.,54 and Huber et al.55
ILK de Paulo et al.56
Myosin II Endlich et al.51
Nck1/2 Verma et al.57
Nephrin Fan et al.,50 and Reiser et al.53
P-cadherin Reiser et al.44
Pod1 Davidson et al.58
Podocalyxin Davidson et al.58
Podocin Fan et al.,50 and Reiser et al.53
Synaptopodin Mundel et al.,43 and Davidson et al.58
TRPC6 Reiser et al.59
TGF-b Wu et al.60
VEGF Kretzler et al.,61 and
Iglesias-De La Cruz et al.62
WT-1 Mundel et al.,43 and Davidson et al.58
TGF, transforming growth factor; VEGF, vascular endothelial growth factor; TRPC6,
transient potential receptor 6.
Table 3 | Examples of biological mechanisms and kidneys
diseases that are being studied using podocytes in culture
Biological mechanism/
disease Refs.
Cytoskeleton Asanuma et al.,49,63 Endlich et al.,51
Kobayashi et al.,64–67 and Moller et al.68
Cell cycle Pippin et al.,69 and Griffin et al.70,71
Podocyte survival Schiffer et al.72,73
Signaling de Paulo et al.,56 Davidson et al.,58
Tossidou et al.,74 Peters et al.,75
Huber et al.,76 Jung et al.,77 Guan et al.,78
and Yang et al.79
Cell:cell adhesion Reiser et al.,53 and Hunt et al.80
Cell:matrix adhesion Reiser et al.48,81
Channel physiology Endlich et al.,68 Huber et al.,82
Bek et al.,83,84 and Henger et al.85
Diabetic nephropathy Iglesias-De La Cruz et al.,62 and
Susztak et al.86
HIV associated nephropathy He et al.,87 Husain et al.,88 and
Schwartz et al.89
HIV, human immunodeficiency virus.
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proper temperature of the incubator is paramount. If
the actual temperature is too low, the T antigen will be only
partially degraded, thereby preventing the cell from cell-cycle
exit. It is not recommended to expose the podocytes to
temperatures higher than 371C to avoid the induction of heat
shock, which in turn causes cell stress.
To generate podocyte lines from the H-2Kb-tsA58
transgenic Immortomouse42 or from knockout mice after
crossing with the Immortomouse,49,53 kidneys are removed
and glomerular isolation is performed by sterile dissociation
of minced kidney cortex on a series of differential sieves.43
Glomeruli are captured on the smallest sieve, resuspended in
media supplemented with INF-g (100 U/ml), placed on type I
collagen-coated plates, and incubated at 331C. Alternatively,
to promote initial cell outgrowth, one group (PM) routinely
now grows the isolated glomeruli for 3–5 day at 371C in high-
dose INF-g (100 U/ml) containing medium before shifting
them to 331C and 50 U/ml of INF-g. Once stable clonal cell
lines have been established, the concentration of INF-g
should be gradually decreased to a maintenance level of
10–20 U/ml.43 As soon as islets of cobblestone-shaped
podocyte outgrowing from isolated glomeruli become visible
(usually after 4–7 days), the separation from glomerular cores
and contaminating tubular fragments can be conducted.
Here, two approaches have been used. In the classical
approach, the outgrowths are trypsinized and passed over a
25-mm sieve to remove glomerular cores and tubular
fragments.43 The cells are then replated, expanded, and
stocks of this pool are frozen as an initial backup. To generate
monoclonal cell lines, the pool undergoes limiting dilution
cloning and individually growing clones are then identified as
podocytes by immunofluorescence microscopy for WT-143
and podocin, which is also expressed under permissive
conditions. WT-1- and podocin-expressing clones are then
transferred to 371C in the absence of INF-g to induce growth
arrest and differentiation. After 14 days at 371C, the T antigen
should be completely degraded (which should be verified by
Western blot and immunofluorescence microscopy) and the
cells should have exited the cell cycle and have completely
stopped proliferating.43 At this stage, differentiation must be
confirmed by immunolabeling for synaptopodin.43 With this
approach, we initially identified several wild-type podocyte
cells lines, termed MPC cells.43 As discussed above, the
subsequent and still ongoing analysis of these cells confirmed
the expression of virtually all proteins described in podocytes
in vivo to date (Table 2).
Alternatively, outgrowths from decapsulated glomeruli
missing Bowman’s capsule can be isolated using cloning
cylinders. After replating at a low density (1.8 cells/cm2) to
generate colonies from single cells, colonies with characte-
ristic podocyte morphology are identified and reisolated
using cloning cylinders. Again, the potential podocyte lines
are then ready for further phenotypical and functional
characterization as described above.
Similar to undifferentiated primary podocytes in cul-
ture,38 the actively proliferating conditionally immortalized
podocytes growing under permissive conditions display an
epithelial morphology.43 They are small in size, exhibit a
polygonal or ‘cobblestone’ appearance, and have a relatively
small cytoplasmic volume (Figure 1a). When podocytes are
placed in growth restrictive conditions (371C without INF-g),
again similar to primary differentiated podocytes,38 they
substantially increase in size, stop replicating, and take on a
more complex arborized morphology (Figure 1b)43 including
the formation of cellular structures comparable with filtra-
tion slits in vivo44 (Figure 2). Podocytes are typically plated in
growth-restrictive conditions at a concentration of
5000–10 000 cells/cm2.
A word of caution about cultured podocytes: like most
cultured cells, the longer podocytes are maintained in
culture, the greater the chance for spontaneous mutations
leading to transformation. This is particularly important
because immortalized podocytes carry a conditional T
antigen. Therefore, a large bank of low passage stocks should
be cryopreserved and individual aliquots should not be used
for more than 10 to 15 passages. In addition, the
responsiveness to INF-g withdrawal under permissive condi-
tions, the effective growth arrest after 14 days at 371C as
well as the expression of podocyte makers (Table 2) should
be confirmed on a regular basis, that is for every fresh
passage used. In addition, maintaining cells at high density
can induce tumor-like transformation resulting in foci
of cells with reduced contact inhibition or aberrant growth
(Figure 3a). On replating, the transformed cells will initially
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Figure 3 | Comparison of properly and nonproperly cultured
podocytes. (a) Left panel: subconfluent proliferating podocytes with
typical cobblestone morphology ready for subcultivation. Right
panel: overgrown cells displaying dome formation and tumor-like
irregular morphologies. These cells need to be discarded. (b) Left
panel: homogenous population of well differentiated arborized
podocytes after 14 days at 371C. Right panel: in addition to
differentiated podocytes, subpopulations of dividing,
nondifferentiating cells can be found (arrows). The presence of such
nondifferentiating cells can, among others, result from the replating
of overgrown cells shown in (a) or from insufficient use of INF-g under
permissive conditions.
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appear normal, but they have acquired a growth advantage
and therefore eventually will ‘overtake and overrun’ the
culture. Because of their growth advantage, these cells do not
respond to the change in culture temperature or removal of
INF-g and appear as foci of proliferating cells in growth-
restrictive conditions (Figure 3b). Once transformed popula-
tions are present, it is very difficult, if not impossible, to
eliminate them. Thus, transformed cultures should therefore
always be discarded.
ALTERING PODOCYTE GENE EXPRESSION IN CULTURE:
APPLYING STATE OF THE ART MOLECULAR TOOLS
Gene expression and gene silencing are invaluable tools in
understanding podocyte biology. However, like other post-
mitotic cells such as neurons or cardiac myocytes, podocytes
show relatively low transfection efficiency, typical ranging
between 10 and 20 % for cells grown under permissive
conditions. Over the past few years, an array of new
transfection reagents have been introduced that allowed the
successful podocyte transfection of podocytes, in particular
of green fluorescent protein or otherwise tagged proteins to
visualize transfected cells.49,53,63,68 It is critical that one
carefully quantitates transfection efficiency. A simple way to
determine transfection efficiency is to transfect the cells with
a green fluorescent protein vector, visualize the nuclei of all
cells with 4,6-diamidino-2-phenylindole and determine the
percentage of green fluorescent protein-expressing cells.
Under optimized conditions,49 we routinely achieve 10–20%
transfection efficiency for proliferation cells grow at 331C.
Transient transfection dose not provide incorporation of
DNA into the genome and is lost on mitosis. Owing to loss of
expression in daughter cells following mitosis, transient
transfection is not ideal for podocytes in growth-permissive
conditions. However, transient transfection is simpler to
perform and less time consuming than stable transfection or
viral transduction.
Stable transfection has several advantages over transient
transfection in that it does result in gene incorporation into
the genome. This allows for expression to be transmitted to
several generations of daughter cells before being lost. In
addition, stable transfection utilizes cotransfection with a
growth selection advantage, which results in cultures with
virtually all cells expressing the transgene. One disadvantage
of stable transfection is that because the gene must still be
introduced to the cell and incorporated into the genome,
efficiency is usually low, which results in a small number of
cells surviving selection. Because of this, selection and
expansion of stable transfectants is somewhat time-consum-
ing, taking typically between 2 and 3 months for the
generation of the stable cell lines. Nevertheless, we have
successfully used this approach for the stable overexpres-
sion53 or knockdown49 of proteins in podocytes.
WHERE IS THE FIELD HEADING?
As with other postmitotic cells, viral transduction is emerging
as the ideal method for the alteration of gene expression in
podocytes in culture. Viral transduction is accomplished by
transfecting an expression vector into a viral particles
producing cell line. Viral particles are shed into the medium,
which is transferred onto podocytes for infection. Viral
transduction incorporates the advantages of stable transfec-
tion including the continuous expression and selection
capacity with better introduction into the cell than transient
transfection. In addition, viral particles containing media can
be frozen for later use. Most significantly, viral transduction
of cDNAs or shRNAs, for example through retroviral,87
adonoviral,72 or lentiviral vectors (PM, unpublished results),
can also be achieved in growth-arrested, differentiated
podocytes maintained under nonpermissive conditions. We
are currently developing optimized protocols for the
lentiviral infection of differentiated podocytes, both for
protein overexpression and RNAi knockdown studies.
Together with an updated detailed protocol for the cultiva-
tion of podocytes, we will make them available on the
homepage of the Mundel Lab (www.mssm.edu/labs/mundel/),
after they have been validated.
PITFALLS AND TROUBLESHOOTING: THE ACHILLES HEEL
OF CELL CULTURE
It is critical that maticulate attention be paid to all details of
podocyte culture to maximize the benefits of this model
system and to prevent false-positive and false-negatives. Like
any cell system, devoted care is paramount for consistency.
An incomplete list of typical pitfalls with podocyte cultures is
compiled in Table 4.
Pitfall no 1: Not enough care: similar to hippocampal
neurons in cultures,93 podocytes in culture require very
careful handling, thus ensuring highly reproducible results
with respect to differentiation and expression of podocyte-
specific molecules. The cells are conditionally immortalized
and thus very sensitive to minute changes in temperature as
low as 11C.
Pitfall no 2: Loss of sterile conditions: the cultures
should always be maintained under sterile conditions and
mycoplasma-free reagents must be used to prevent myco-
plasma infection. Contamination with mycoplasma leads to
decreased proliferation and the formation of long, thin,
highly branched spine bearing processes, and should be
tested for on a regular basis.
Table 4 | Typical pitfalls in culturing podocytes
Overcrowding of proliferating cells over the weekend causing second hit
Inadequate concentration of IFN-g at 331C
Impaired proliferation at 331C owing to omission of type 1 collagen
Inadequate dispersion after splitting before replating
Loss of IFN-g-specific activity owing to repeated freeze–thawing
Variable plating density at replating
Not long enough differentiated at 371C
Presence of nondifferentiating subcolonies at 371C
Incorrect incubator temperature, both at 331C or 371C
Mycoplasma infection
Too high number of passages
IFN, interferon.
32 Kidney International (2007) 72, 26–36
r e v i e w SJ Shankland et al.: Podocytes in culture
Pitfall no 3: Loss of proliferative stimuli under permissive
conditions: although type IV collagen is the major com-
ponent of the glomerular basement membrane, under
permissive conditions, the cultured podocytes grow faster
and better on type I collagen and overall the cells appear
more healthy. Type I collagen has to be coated to the cell-
culture dish for at least 1 h before removal and rinsed twice
with phosphate-buffered salines. Within 12 h of seeding
under permissive conditions, mitotic cells should become
obvious in most fields. The use of other matrices or plastic
may be desired depending on the experimental protocol but
changes in proliferation and differentiation have to be
anticipated and accounted for in the interpretation of the
data. Uneven cell growth may occur and confluent patches
may develop if the cells are not thoroughly dispersed after
splitting before replating. To preserve the activity of INF-g,
working aliquots should be kept frozen and thawed only once
when ready for use. As a general rule, cultures should not be
become more than 80–95% confluent to prevent irreversible
loss of contact inhibition and multilayering (Figure 3a).
Pitfall no 4: (the biggest one of all) The ‘Friday-to-
Monday gap’: overgrowing permissive cultures is one, if not
the major, reasons for podocyte culture failure later on. This
is a key point. In contrast to many other cells (e.g., mesangial
cells, fibroblasts, human embryonic kidney cell line 293,
Madin–Darby canine kidney cells, COS7 cells, etc), podocytes
do not tolerate the typical ‘Friday-to-Monday gap’. If
podocytes overgrow during this or any time period, they
will suffer a ‘second hit-like insult’ that will lead subsequently
to a loss of differentiation. This insult is irreversible and
cannot be rescued by simply replating the overgrown cells at a
lower density, even if the cells appear morphologically
normal after replating. Instead, they need to be discarded
and replaced with a fresh aliquot. This is probably the single
most frequent mistake that is made while culturing these
podocyte cell lines, thereby causing the above-discussed
claims (Table 1) including the loss of nephrin expression in
culture. When the desired confluency is reached (80–95%),
the podocytes need to be subcultured.
Pitfall no 5: Inconsistent replating/passaging: for the
detachment of the cells for the purpose of replating/passaging
cells, the culture medium is removed and the dish is rinsed
with phosphate-buffered saline, followed by incubation with
prewarmed fresh 0.05% trypsin/ethylenediaminetetraacetic
acid solution (5ml per T75 flask). This is time sensitive (no
more than 5–7min) to avoid cell death. While preparing the
next passage of cells, T75 flasks precoated with type I
collagen, should be inoculated with 150 000–200 000 cells at
371C. Podocytes growing at 331C can be inoculated as low as
50 000 cells per T75 flask because the cells proliferate well in
the presence of 10–20 U/ml of IFN-g. It is essential to allow
the cells to become quiescent and differentiate for at least 14
days before they express the entire panel of marker proteins
described above (Table 2). Finally, as a general rule it is also
important to recognize that if on day 14 after thermoshift to
371C and removal of IFN-g, the cells continue to proliferate
(Figure 2b) and do not express the podocyte-marker proteins
listed in Table 3, they are most probably constitutively
immortalized and should be discarded.
THE FUTURE: AN OUTLOOK
With the rapid and exciting pace of discovery of novel
podocyte genes, several genetically altered mice have been
generated. It therefore comes as little surprise that there is a
growing number of wild-type and knockout murine as well as
wild-type and genetically altered human podocyte lines
available for cell-culture studies (Table 5). There are now
several other new podocyte cell cultures available too. These
include coculture studies of podocytes and glomerular
endothelial cells in an attempt to better study permeability,
growing podocytes in matrigel for a three-dimensional effect,
Table 5 | Currently available podocyte cell lines in vitro based
on published literature (at the time of submitting the
manuscript)
Podocyte cell line Refs.
Wild-type mouse Mundel et al.43 and Schiwek et al.46
a3 Integrin/ Reiser et al.53
CD2AP/ Schiffer et al.73
FGF2/ Davidson et al.58
Cyclin I/ Griffin et al.71
p21/ Wada et al.97 and Petermann et al.98
p27/ Petermann et al.98
Synaptopodin/ Asanuma et al.49
HIV transgenic Schwartz et al.89
Wild-type human Saleem et al.99
DDS mutant human Viney et al.100
HIV, human immunodeficiency virus.
Table 6 | Proposed criteria required to classify a cell in culture
as a podocyte
Feature Details
Morphology Arborized appearance
Processes extend from cell body
Large cytoplasmic to nuclear volume ratio
Stress fiber formation
Protein expression WT-1
Synaptopodin
Nephrin
Podocin
CD2AP
Ezrin
VEGF production
Cell cycle Absence of DNA synthesis (negative for Brdu,
PCNA, cyclin E, and A; no cdk2 activity)
Absence of mitosis (negative for cyclin B,
no cdc2 activity; no mitotic figures)
Expression of p27 and p57
Do not require cell–cell contact to exit cell
cycle
Functional responses Apoptosis induced by TGF-b, PAN
Motile
Processes induced by ATRA
Dexamethasone induces shape changes and
enhanced survival
ATRA, all-trans retinoic acid; PAN, puromycin aminonucleoside; PCNA, proliferating
cell nuclear antigen; TGF, transforming growth factor; VEGF, vascular endothelial
growth factor.
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or growing podocytes that were isolated from the urine.94 To
hasten the process, we (SJS and JP) have recently developed a
system whereby we utilize a biotinylated antibody against
mouse podocytes that is linked to a magnetic bead. Following
the incubation of the glomerular preparation to the antibody,
a magnet is used to separate the podocytes from the other
cells, thus circumventing the use of cell-specific cloning.
In summary, the availability of conditionally immortalized
differentiated podocytes in culture has developed into an
indispensable tool for the mechanistic analysis of podocyte
function. In combination with animal models and human
studies to confirm the in vitro results, the study of podocytes
in culture is a valid and invaluable model system that will
continue providing novel insight into the function of these
unique cells in health and disease. Finally, what are the
criteria that should be used to characterize a cell in culture as
a podocyte? In keeping with well-defined criteria for other
cells such as neurons and cardiomyocytes, we have proposed
a set of strict criteria that is essential to define a cell in vitro as
a true podocyte. These are described in Table 6.
In conclusion, we would like to indicate that requests for
freely available ‘quality-controlled’ podocytes and requests
for ‘hands-on’ introduction to podocyte cell culture in our
laboratories are welcome and even encouraged. Enquiries
may be addressed to PM (peter.mundel@mssm.edu), JR
(jreiser@partners.org), or SJS (stuartjs@u.washington.edu).
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Appendix: A detailed protocol for the cultivation of
conditionally immortalized podocytes
Morphology
Epithelial under permissive conditions.
Mesenchymal, process bearing under nonpermissive conditions.
Description
Conditionally immortalized mouse podocyte cell lines were
established from the Immortomouse, which carries a
thermosensitive (ts58A) variant of the SV 40 T antigen as a
transgene. T-antigen expression can be stimulated by mouse
IFN-g. Proliferating cells express WT-1 and podocin. They
differentiate within 14 days when grown under nonpermis-
sive conditions in the absence of IFN-g. Differentiated cells
develop prominent processes and express synaptopodin.
Handling of frozen cells
If on arrival, continued storage of the frozen cells is necessary,
the vials should be stored in liquid nitrogen and not at
801C. Storage at 801C will result in loss of viability.
Thawing of cells
1. Prepare a collagen-coated 75 cm2 tissue culture flasks.
2. Thaw cells rapidly (within 2 min) in a 371C water bath.
3. Spin down at 600 g for 5 min.
4. Resuspend pellet and transfer to flask.
5. Add 25 ml medium.
6. Add 50 U/ml IFN-g (can be reduced to 10–20 U/ml later on).
7. Place the cells in an incubator set at 331C.
8. Verify correct temperature of incubator with thermo-
meter.
Medium renewal
1. Change medium every second day (we mean it!).
2. Avoid ‘Friday-to-Monday gap’.
3. Always add IFN-g when growing cells under permissive
conditions.
Subcultivation
1. Never allow the cultures to become 100% confluent.
2. Use cells at 80–95 % confluence.
3. Remove and discard culture medium.
4. Briefly rinse the cell layer with phosphate-buffered
saline.
5. Add 5 ml trypsin–ethylenediaminetetraacetic acid solu-
tion to flask.
6. Incubate at room temperature for 5–6 min.
7. Monitor detachment of cells under microscope.
8. Shake flask carefully to completely detach cells completely.
9. Put content in 50 ml Falcon tube (A).
10. Add 35 ml medium to inactivate trypsin to a total
volume of 40 ml.
11. Transfer 16 ml from tube A in new Falcon tube (B).
12. Spin cells at 2300 r.p.m. (600 g) for 5 min, discard
supernatant.
13. Respuspend pellet of tube B in 3 ml freezing medium.
14. Freeze two aliquots of 1.5 ml each.
15. Resuspend pellet from tube A in 4 ml medium.
16. Transfer 1 ml of cell suspension into each new 75-cm2
flask.
17. Add 25 ml medium and IFN-g.
The cells should be grown for the first two passages with 50
or 100 U/ml IFN-c, then for two passages with 20 U/ml IFN-c
and finally with 10 U/ml IFN-c for continuing culture
Thermoshift to 371C. Always subculture cells before thermo-
shift.
Verify correct temperature of incubator with thermometer.
Plate a 1:10 to dilution from a 95% confluent layer.
Complete growth medium. RPMI 1640 medium with
glutamine (Gibco).
10 % fetal bovine serum.
100 units/ml Pen/Strep (Gibco).
Cryoprotectant medium. Complete culture medium sup-
plemented with 8% (v/v) dimethylsulfoxide.
Collagen coating.
1. All cell culture dishes should be coated with 0.1 mg/ml
type I collagen.
2. Incubate for 1 h at 371C with collagen solution.
3. Remove collagen solution.
4. Rinse once with phosphate-buffered saline.
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